Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm

Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03641326	Sunitinib in Sarcomas of the Central Nervous System	terminated	Phase 2	5	National Cancer Institute (NCI)NIH	1	Apr 19, 2022	clinicaltrials
NCT01125046	Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	completed	Phase 2	50	Northwestern UniversityOTHER	1	Jan 22, 2021	clinicaltrials
NCT01024907	Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas	completed	Phase 1 / Phase 2	23	Abramson Cancer Center at Penn MedicineOTHER	1	Dec 10, 2020	clinicaltrials
NCT00045734	Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Data updated 23 days agoSource updated Apr 19, 2022source: clinicaltrials